Back to results
US 11,708,337 B2Granted
Synthesis of 1,4-diazaspiro[5.5]undecan-3-one
AssigneeG1 Therapeutics, Inc.
InventorsStephen E. Schneider, Hannah White, Thomas Fessard, Sagar Beldar
Life of this patent
Estimating the term…
Abstract
This invention provides a process for preparing 1,4-diazaspiro[5.5]undecan-3-one and analogues thereof that are useful in the preparation of pharmaceutical compound, including for the treatment of disorders involving abnormal cellular proliferation. Chemical intermediates in the process are also provided.
Claims26
A process to prepare a spirocyclic compound comprising:
- a. reacting a cyclic ketone with a nitroalkane to afford a cycloalkyl group substituted with nitroalkylene;
- b. reacting the compound of step (a) with a glycinate to afford a compound of Formula III;
- c. reducing the compound of Formula III with a reducing agent;
- d. cyclizing the compound of step (c);
- wherein the cyclic ketone is of Formula:
- wherein the nitroalkane is of Formula:
- wherein the glycinate is of Formula:
- wherein Formula III is:
- wherein the spirocyclic compound is of Formula:
- wherein
- y is 0;
- n is 0 or 1;
- R1 is hydrogen;
- R2 is hydrogen, substituted heteroaryl, or
- R3 is hydrogen;
- R4 is NR8R9 or OR10;
- R5 and R6 are independently selected from the group consisting of hydrogen, alkyl, aryl, -alkyl-aryl, and —C(O)R11;
- R7 is alkyl, aryl, or -alkyl-aryl;
- R8 and R9 are independently selected from the group consisting of hydrogen, alkyl, aryl, and -alkyl-aryl;
- R10 is alkyl, aryl, or -alkyl-aryl;
- R11 is alkyl or aryl;
- R12 is alkyl, aryl, or -alkyl-aryl;
- R13 is —S-alkyl or Cl.
20 more elements
A compound of Formula
- or an acceptable salt thereof;
- wherein
- y is 0, 1, 2, 3, or 4;
- n is 0 or 1;
- R1 is hydrogen, alkyl, or aryl;
- R2 is hydrogen, substituted heteroaryl, or
- R3 is hydrogen, NR5R6, OR7, SR7, or halogen;
- R4 is NR8R9 or OR10;
- R5 and R6 are independently selected from the group consisting of hydrogen, alkyl, aryl, -alkyl-aryl, and —C(O)R11;
- R7 is alkyl, aryl, or -alkyl-aryl;
- R8 and R9 are independently selected from the group consisting of hydrogen, alkyl, aryl, and -alkyl-aryl;
- R10 is alkyl, aryl, or -alkyl-aryl;
- R11 is alkyl or aryl;
- R12 is alkyl, aryl, or -alkyl-aryl;
- and
- R13 is —S-alkyl or Cl;
- each instance of R50 is independently selected from the group consisting of hydrogen, halogen, and alkyl.
14 more elements
A process to prepare a compound of Formula III comprising:
- a. reacting a cyclic ketone with a nitroalkane to afford a cycloalkyl group substituted with nitroalkylene;
- b. reacting the compound of step (a) with a glycinate;
- wherein the cyclic ketone is of Formula:
- wherein the nitroalkane is of Formula:
- wherein the glycinate is of Formula:
- wherein Formula III is:
- wherein
- y is 0;
- n is 0 or 1;
- R1 is hydrogen;
- R2 is hydrogen, substituted heteroaryl, or
- R3 is hydrogen;
- R4 is NR8R9 or OR10;
- R5 and R6 are independently selected from the group consisting of hydrogen, alkyl, aryl, -alkyl-aryl, and —C(O)R11;
- R7 is alkyl, aryl, or -alkyl-aryl;
- R8 and R9 are independently selected from the group consisting of hydrogen, alkyl, aryl, and -alkyl-aryl;
- R10 is alkyl, aryl, or -alkyl-aryl;
- R11 is alkyl or aryl;
- R12 is alkyl, aryl, or -alkyl-aryl;
- R13 is —S-alkyl or Cl.
17 more elements
Dependencies are inferred from the claim text.